ArticleBMC proceedings2026
Challenges and opportunities in combating viral hepatitis in India: insights from the Indian Hepatitis Summit 2025.
Article in BMC proceedings, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe world has committed to ending viral hepatitis as a public health threat as part of sustainable development goal 3.3. World Health Organization (WHO) has developed Global Health Sector Strategies (GHSS 2022-2030) to provide guidance to countries to end viral hepatitis by 2030. India instituted the national program for prevention and control of viral hepatitis (National Viral Hepatitis Control Program, NVHCP) in 2018 in alignment with the global perspective and strategic framework. The Chennai Liver Foundation conducted the first Indian Hepatitis Summit 2025 as a collective movement towards a hepatitis-free India.
methodsThe summit was conducted on January 17-18, 2025, at Chennai. Healthcare professionals, policymakers, advocates, researchers, and civil society representatives gathered to share successes, discuss barriers, and address the urgent challenges of viral hepatitis and promote collaborative efforts to combat this silent epidemic in India.
resultsThe meeting was attended by 54 program faculty and 275 delegates from government agencies, national and international organizations, and public and private hospitals. The two-day agenda included 14 sessions, with 46 talks and four panel discussions. The summit gathered important lessons from global initiatives, surveyed the current landscape of viral hepatitis in India, shared the best practices from some parts of world including India, identified barriers to elimination initiatives, and discussed potential solutions to overcome these barriers. Discussions also included the developments in viral hepatitis screening, diagnosis, and treatment; the ways to tackle the stigma associated with the illness; and innovative measures to improve public health results. In collaboration with Indian Council of Medical Research (ICMR) and National Institute of Epidemiology (NIE), the Chennai Liver Foundation launched the Hepat App and a Hepatitis Online Course.
conclusionThe summit served as a platform to raise awareness about the importance of prevention, early diagnosis, and effective treatment options; and to delineate future directions for viral hepatitis elimination in India.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.